Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2014
Chem-seq permits identification of genomic targets of drugs against androgen receptor regulation selected by functional phenotypic screensChunyu Jin, Liuqing Yang, Min Xie, et al.
Oncogene|January 3, 2023
Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancerJoy C Yang, Pengfei Xu, Shu Ning, et al.
Genes & Cancer|September 3, 2010
Autophagy Blockade Sensitizes Prostate Cancer Cells towards Src Family Kinase InhibitorsZhaoju Wu, Pei-Ching Chang, Joy C Yang, et al.
Nature Communications|November 18, 2018
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancerChengfei Liu, Wei Lou, Joy C Yang, et al.
Communications Medicine|September 26, 2022
Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomesShu Ning, Jinge Zhao, Alan P Lombard, et al.
Plos One|August 23, 2013
CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitorsWenchang Guo, Ruiwu Liu, Gaurav Bhardwaj, et al.
Nature Medicine|March 29, 2016
ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancerJunjian Wang, June X Zou, Xiaoqian Xue, et al.
Science Translational Medicine|May 4, 2018
Development of a stress response therapy targeting aggressive prostate cancerHao G Nguyen, Crystal S Conn, Yae Kye, et al.
Nature Communications|August 5, 2024
Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancerPengfei Xu, Joy C Yang, Bo Chen, et al.
Oncogene|August 4, 2018
KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPCHung-Jung Wang, Mamata Pochampalli, Ling-Yu Wang, et al.
Pageof 4